Coeptis Therapeutics Holdings, Inc.
COEP
$13.21
-$0.445-3.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.45% | -1.88% | 48.13% | 71.20% | 5.22% |
| Total Depreciation and Amortization | 26.71% | 17.74% | 2.12% | -0.82% | -3.68% |
| Total Amortization of Deferred Charges | -- | -33.40% | -- | -- | -- |
| Total Other Non-Cash Items | -13.08% | -17.13% | -74.62% | -105.25% | 85.99% |
| Change in Net Operating Assets | -3,765.33% | -384.17% | -104.91% | -157.64% | -106.66% |
| Cash from Operations | -69.06% | -24.38% | 15.19% | 3.36% | 25.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 100.00% |
| Cash from Investing | -- | -- | -- | -100.00% | 100.00% |
| Total Debt Issued | -100.00% | -26.67% | -100.00% | 100.00% | -85.25% |
| Total Debt Repaid | 100.00% | 23.90% | 81.86% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -94.29% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -92.62% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99.98% | -- | -100.00% | -- | -- |
| Cash from Financing | -93.56% | 290.51% | -58.20% | 755.85% | -42.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -532.03% | 949.17% | -1,149.65% | 77.22% | -53.80% |